Biblio
(2019).
A Novel Disease Risk Model for Patients with AML Receiving Allogeneic Hematopoietic Cell Transplantation.Biol Blood Marrow Transplant.
(2019). (2016). (2016).
Haploidentical Hematopoietic Stem Cell Transplantation as Platform for Post-transplant Cellular Therapy.Biol Blood Marrow Transplant.
(2015).